Med Health Services Management, LP

Med Health Services Management, LP was paid $1.70M by Medicaid between Jan 2018 and May 2023, across 70 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 80% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Pennsylvania

Rank by total paid#18 of 95

Median peer was paid$153K

This provider vs. median11×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	10,729	$174K
2019	12,646	$82K
2020	21,928	$635K
2021	46,413	$623K
2022	18,189	$178K
2023	1,416	$3K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	80%	43,358	16,572	$1.35M
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	3.0%	10,259	4,163	$50K
80074		2.2%	1,383	1,179	$38K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	1.3%	10,252	5,644	$22K
80053	Comprehensive metabolic panel	1.3%	7,018	4,385	$21K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	1.1%	1,719	1,194	$19K
81408		<1%	211	101	$16K
81406		<1%	214	103	$12K
81404		<1%	211	101	$12K
80061	Lipid panel	<1%	2,705	1,838	$11K
80050	General health panel	<1%	661	446	$10K
84443	Thyroid stimulating hormone (TSH)	<1%	2,249	1,471	$8K

58 more codes

82607		<1%	980	$8K
80048	Basic metabolic panel (calcium, ionized)	<1%	4,787	$8K
82746		<1%	665	$6K
81405		<1%	109	$6K
82728		<1%	837	$6K
81317		<1%	107	$6K
83036	Hemoglobin; glycosylated (A1C)	<1%	2,463	$6K
81292		<1%	93	$6K
81298		<1%	94	$6K
81321		<1%	93	$6K
81295		<1%	94	$5K
36415	Collection of venous blood by venipuncture	<1%	7,475	$5K
83550		<1%	885	$5K
81211		<1%	46	$5K
83735		<1%	1,505	$5K
83540		<1%	912	$4K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	49	$4K
82977		<1%	916	$4K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	46	$3K
85652		<1%	892	$2K
84550		<1%	293	$2K
86431		<1%	231	$2K
81001		<1%	1,390	$2K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	43	$2K
81201		<1%	92	$1K
84480		<1%	232	$1K
86225		<1%	156	$1K
86038		<1%	157	$1K
86618		<1%	96	$1K
84436		<1%	303	$1K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	50	$494.66
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	50	$465.60
85045		<1%	257	$436.69
87086	Culture, bacterial; quantitative colony count, urine	<1%	703	$403.25
87486		<1%	50	$377.22
86709		<1%	103	$369.38
86617		<1%	26	$315.39
87640		<1%	36	$280.41
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	16	$258.68
86708		<1%	34	$236.85
83721		<1%	253	$227.68
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	67	$206.44
82550		<1%	75	$200.73
84134		<1%	81	$101.34
80164		<1%	55	$96.31
P9603	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled	<1%	2,135	$90.55
86140		<1%	303	$82.06
85610		<1%	110	$49.79
87581		<1%	15	$45.03
87088		<1%	164	$39.75
87186		<1%	164	$36.51
85027		<1%	45	$22.80
80076		<1%	96	$15.14
84439		<1%	36	$4.06
84100		<1%	22	$0.95
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	0%	26	$0.00
81162		0%	52	$0.00
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	0%	16	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKONDEL, JANICE (DIRECTOR)